A REVOLUTIONARY DEVELOPMENT IN FAMILY PLANNING
In recent years, the age of menopause can be estimated by measuring how fast the woman’s biological clock works with a simple hormone test performed on the blood of the expectant mother. The name of this test, which reveals how much more women can delay the birth process, which is postponed until later due to career concerns, is called AntiMüllerian Hormone (AMH). With this development that will revolutionize family planning, it can be learned when a woman will enter menopause and how long she can delay giving birth.
Importance of Amh hormone test in determining egg reserve
Increasing studies in reproductive medicine focus on what can be the best indicator for determining ovarian function. In the evaluation of ovarian reserve, FSH and estradiol tests were performed on the second or third day of menstruation in recent years, and these results were evaluated together with the egg reserve data seen on ultrasound.
Medical developments now show that one of the tests that can indirectly show the ovarian reserve is the hormone amh (antimullerian hormone).
With this test, it is approximately possible to understand how much time is left to have a child by looking at the age and AMH value of the expectant mother.
Before this test, the obstetrician performs an ultrasound on the mother-to-be on the first day of menstruation and counts the eggs. Although the number of eggs shows the condition of the reserve in the patient’s eggs, it does not give information about how long this situation will continue. In this case, the AMH test comes into play. With the result of this test, the expectant mother can get information from her doctor about how close she is to menopause. Our studies show that women who want to postpone becoming a mother can plan to have a child by looking at the results of this test.
When is the amh test done?
The Amh test can be performed at any time independent of the menstrual period to evaluate the ovaries.
The importance of AMH value in IVF Treatment
In IVF, amh hormone can be used as a data for the evaluation of ovarian reserve, treatment planning and evaluation of IVF treatment. Evaluation with ultrasound is invaluable. When we perform IVF treatment, we can measure how many eggs we can obtain with high precision before the treatment. In recent years, we have been able to identify cases with a low chance of success with antimullerian hormone.
Op.Dr Tolga Ecemis
Gynecology, Obstetrics and IVF Specialist